Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, and Key Laboratory of Molecular Biology (Brain Diseases), Anhui University of Chinese Medicine, Hefei, 230012, China.
Center for Xin'an Medicine and Modernization of Traditional Chinese Medicine of IHM, and Key Laboratory of Molecular Biology (Brain Diseases), Anhui University of Chinese Medicine, Hefei, 230012, China; Acupuncture and Moxibustion Clinical Medical Research Center of Anhui Province, The Second Affiliation Hospital of Anhui University of Chinese Medicine, Hefei, 230061, China.
J Ethnopharmacol. 2024 Apr 6;323:117713. doi: 10.1016/j.jep.2024.117713. Epub 2024 Jan 3.
Anshen Dingzhi prescription (ADP), which was first published in the masterpiece of traditional Chinese Medicine in the Qing Dynasty, "Yi Xue Xin Wu" (1732 CE), is documented to interrupt panic-related disorders. However, the mechanism of its action is still not clear.
This study aims to investigate the effects of ADP on post-traumatic stress disorder (PTSD)-like behaviors and explore the mechanism from perspective of sirtuin1 (SIRT1)-peroxisome proliferator-activated receptor gamma co-activator 1 alpha (PGC-1α)-dependent mitochondrial function.
The changes of SIRT1-PGC-1α signal and mitochondrial function were evaluated in the hippocampus of mice receiving single prolonged stress (SPS). Later, the roles of this signaling pathway played in fear memory generalization and anxiety-like behavior in SPS mice was investigated using two agonists of this signaling pathway. On this basis, the effects of ADP (36.8 mg/kg) with definite therapeutic effects, on mitochondrial function were investigated and further confirmed by a SIRT1 inhibitor. Finally, the possible components of ADP targeting PGC-1α were monitored through bioinformatics.
Compared with control mice, SIRT1-PGC-1α signal in the hippocampus was impaired in SPS mice, accompanied with dysfunction of mitochondria and abnormal expression of synaptic proteins. The agonists of SIRT1-PGC-1α signal, ZLN005, as well as resveratrol improved the behavioral changes of mice caused by SPS, reversed the decline of proteins in SIRT1-PGC-1α signal, mitochondrial dysfunction, and the abnormal expression of synaptic proteins. The fingerprint was established for the quality control of ADP. At a dose of 36.8 mg/kg, ADP could prevent fear memory generalization and anxiety-like behavior in SPS mice. Mechanically, ADP promoted SIRT1-PGC-1α signal and repaired mitochondrial function. Importantly, SIRT1 inhibitor, selisistat eliminated the ameliorative effects of ADP on behavioral and mitochondrial function. Through molecular docking simulation, the brain-entering components of ADP, including malkangunin, Rg5, fumarine, frutinone A, celabenzine, and inermin had high binding energy with PGC-1α.
Dysfunction of SIRT1-PGC-1α-dependent mitochondrial function is attributed to SPS-triggered fear generalization and anxiety-like behavior, and ADP could improve PTSD-like behaviors likely through activating this signaling pathway.
民族药理学相关性:安神定志方(ADP)最早见于清代中医名著《医心悟》(公元 1732 年),被证明可中断与恐慌相关的疾病。然而,其作用机制尚不清楚。
本研究旨在探讨 ADP 对创伤后应激障碍(PTSD)样行为的影响,并从 SIRT1-过氧化物酶体增殖物激活受体γ共激活因子 1α(PGC-1α)依赖性线粒体功能的角度探讨其机制。
评估单次延长应激(SPS)后小鼠海马中 SIRT1-PGC-1α 信号和线粒体功能的变化。随后,使用该信号通路的两种激动剂研究该信号通路在 SPS 小鼠中恐惧记忆泛化和焦虑样行为中的作用。在此基础上,用具有明确治疗作用的 ADP(36.8mg/kg)研究其对线粒体功能的影响,并通过 SIRT1 抑制剂进一步证实。最后,通过生物信息学监测 ADP 靶向 PGC-1α 的可能成分。
与对照组相比,SPS 小鼠海马中 SIRT1-PGC-1α 信号受损,线粒体功能障碍,突触蛋白表达异常。SIRT1-PGC-1α 信号激动剂 ZLN005 和白藜芦醇改善了 SPS 引起的小鼠行为变化,逆转了 SIRT1-PGC-1α 信号、线粒体功能障碍和突触蛋白异常表达的下降。建立了 ADP 的质量控制指纹图谱。ADP 以 36.8mg/kg 的剂量可预防 SPS 小鼠的恐惧记忆泛化和焦虑样行为。在机制上,ADP 促进 SIRT1-PGC-1α 信号并修复线粒体功能。重要的是,SIRT1 抑制剂 selisistat 消除了 ADP 对行为和线粒体功能的改善作用。通过分子对接模拟,ADP 的脑内进入成分,包括 malkangunin、Rg5、fumarine、frutinone A、celabenzine 和 inermin 与 PGC-1α 具有高结合能。
SIRT1-PGC-1α 依赖性线粒体功能障碍是 SPS 引发的恐惧泛化和焦虑样行为的原因,ADP 可能通过激活该信号通路改善 PTSD 样行为。